Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US8946239B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8946239-B2 |
| Application number | US-17057108-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2008 |
| Priority date | Jul 10, 2008 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides substituted pyrrolo-, furano-, and cyclopentylpyrimidine bicyclic compounds of formula III, and 5,6-saturated and unsaturated and pharmaceutically acceptable salts, prodrugs, solvates, and hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, such as for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula III: and 5,6-saturated and unsaturated with respect to the five membered ring; R 1 is CH 3 when R 2 is a methoxyphenyl group, or wherein R 1 is methoxyphenyl group when R 2 is CH 3 ; R 3 is CH 3 ; R 5 is CH 3 ; R 6 is a hydrogen (H); X is an oxygen (O); and…
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.